BH4 deficiency identified in a neonatal screening program for hyperphenylalaninemia

Journal Title: Jornal de Pediatria - Year 2018, Vol 94, Issue 2

Abstract

Objectives To show the general prevalence and to characterize tetrahydrobiopterin (BH4) deficiencies with hyperphenylalaninemia, identified by the Neonatal Screening Program of the State of Minas Gerais. Methods Descriptive study of patients with BH4 deficiency identified by the Neonatal Screening Program of the State of Minas Gerais. Results The prevalence found was 2.1 for 1,000,000 live births, with a frequency of 1.71% among hyperphenylalaninemias. There were four cases (40%) with 6-pyruvoyl-tetrahydropterin synthase deficiency, three with GTP cyclohydrolase I – autosomal recessive form deficiency, and three with dihydropteridine reductase deficiency (30% each). Six patients were diagnosed due to clinical suspicion and four cases due to systematic screening in neonatal screening. After the start of the treatment, patients identified by neonatal screening had rapid improvement and improved neuropsychomotor development compared to those diagnosed by the medical history. Conclusions The prevalence of BH4 deficiencies in Minas Gerais was slightly higher than that found in the literature, but the frequency among hyperphenylalaninemias was similar. Although rare, they are severe diseases and, if left untreated, lead to developmental delays, abnormal movements, seizures, and premature death. Early treatment onset (starting before 5 months of age) showed good results in preventing intellectual disability, justifying the screening of these deficiencies in newborns with hyperphenylalaninemia identified at the neonatal screening programs for phenylketonuria.

Authors and Affiliations

Cezar Souza

Keywords

Related Articles

Chloride and sodium ion concentrations in saliva and sweat as a method to diagnose cystic fibrosis

Objective Cystic fibrosis diagnosis is dependent on the chloride ion concentration in the sweat test (≥60mEq/mL – recognized as the gold standard indicator for cystic fibrosis diagnosis). Moreover, the salivary glands ex...

Therapeutic hypothermia for hypoxic–ischemic encephalopathy: challenges during transfer and global perspectives

Perinatal asphyxia resulting in hypoxic–ischemic encephalopathy (HIE) occurs in 1–2/1000 live births in high income countries, and 10–20/1000 in low- and middle-income countries (LMICs).1 Worldwide, HIE affects around 2....

Risk factors for neonatal death in the capital city with the lowest infant mortality rate in Brazil

Objectives To analyze the risk factors for neonatal death in Florianópolis, the Brazilian city capital with the lowest infant mortality rate. Method Data were extracted from a historical cohort with 15,879 live births....

Vascular endothelial growth factor and pulmonary hypertension in children with beta thalassemia major

Objective The purpose of this study was to illustrate the association between vascular endothelial growth factor level and pulmonary artery hypertension in children with β-thalassemia major. Method This case–control stu...

The mediator role of psychological morbidity on sleep and health behaviors in adolescents

Objective This study examined the mediation role of psychological morbidity, defined in this study as depression/anxiety, in the relationship between excessive daytime sleepiness and sleep quality, and between sleep habi...

Download PDF file
  • EP ID EP483987
  • DOI 10.1016/j.jped.2017.04.005
  • Views 39
  • Downloads 0

How To Cite

Cezar Souza (2018). BH4 deficiency identified in a neonatal screening program for hyperphenylalaninemia. Jornal de Pediatria, 94(2), 170-176. https://europub.co.uk/articles/-A-483987